SQZ Biotechnologies Return on Tangible Equity 2020-2022 | SQZ
Current and historical return on tangible equity values for SQZ Biotechnologies (SQZ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| SQZ Biotechnologies Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2022-12-31 |
$-0.08B |
$0.06B |
-100.31% |
| 2022-09-30 |
$-0.08B |
$0.07B |
-80.83% |
| 2022-06-30 |
$-0.08B |
$0.09B |
-68.44% |
| 2022-03-31 |
$-0.07B |
$0.11B |
-57.48% |
| 2021-12-31 |
$-0.07B |
$0.12B |
-46.98% |
| 2021-09-30 |
$-0.07B |
$0.13B |
-50.86% |
| 2021-06-30 |
$-0.06B |
$0.15B |
-49.33% |
| 2021-03-31 |
$-0.06B |
$0.17B |
-60.11% |
| 2020-12-31 |
$-0.05B |
$0.13B |
-103.55% |
| 2020-06-30 |
$-0.03B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.024B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
